BioLineRx (BLRX) Land & Improvements (2019)

BioLineRx (BLRX) posted quarterly Land & Improvements of $1.5 million for Q2 2019.

Analysis

BioLineRx (BLRX) Land & Improvements (2019) Analysis & Trends

BioLineRx's Land & Improvements history runs 1 years deep, the most recent figure standing at $1.5 million for Q2 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Land & Improvements (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	BioLineRx	6.64 Bn	6.64 Bn	235,000.00	-

Historic Data

Download Data